Document Detail


Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome.
MedLine Citation:
PMID:  2004474     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ketoconazole, an imidazole derivative which inhibits adrenal steroidogenesis, has been used with success for the metabolic control of Cushing's disease. Few data are available about the use of ketoconazole in the management of the ectopic ACTH syndrome. We have used ketoconazole in eight patients: four patients with Cushing's disease, two patients with overt and two with occult ectopic ACTH syndrome. Among patients with Cushing's disease, reversible hypoadrenalism occurred once. All had full clinical and biochemical regression of the disease for more than 6 months with 400-1200 mg ketoconazole per day. Patients with ectopic ACTH syndrome received 1200 mg ketoconazole per day for at least 2 months. Partial biochemical regression was observed in two and a secondary escape to adrenal blockade in two others. These findings further indicate that ketoconazole is a valuable tool for the metabolic control of Cushing's disease. On the contrary, in ectopic ACTH syndrome, this aim can be impossible to reach with ketoconazole although the reasons for its ineffectiveness remain to be determined.
Authors:
A Tabarin; A Navarranne; J Guérin; J B Corcuff; M Parneix; P Roger
Related Documents :
2246674 - Cushing's syndrome: new variants and association with empty sella syndrome.
2891504 - Ectopic pituitary and hypothalamic hormone syndromes.
3020074 - Ectopic adrenocorticotropin syndrome caused by lung cancer that responded to corticotro...
15316754 - Multicentric castleman's disease complicated by tumor lysis syndrome.
8718994 - Prevalence of dementia in adults with and without down syndrome.
19545994 - A synaptic trek to autism.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical endocrinology     Volume:  34     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  1991 Jan 
Date Detail:
Created Date:  1991-04-25     Completed Date:  1991-04-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  63-9     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, Hôpital Haut-lévèque, Bordeaux-Pessac, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
ACTH Syndrome, Ectopic / diagnosis,  drug therapy*,  metabolism
Adult
Cushing Syndrome / diagnosis,  drug therapy*,  metabolism
Diagnosis, Differential
Female
Humans
Hydrocortisone / blood,  urine
Ketoconazole / therapeutic use*
Male
Chemical
Reg. No./Substance:
50-23-7/Hydrocortisone; 65277-42-1/Ketoconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopath...
Next Document:  Long-term follow-up of treatment of thyrotoxicosis by three different methods.